Proscia Releases Concentriq Embeddings and AI Toolkit for Digital Pathology Research
Proscia has introduced Concentriq Embeddings and the Proscia AI Toolkit as part of its Concentriq platform, providing technical resources for …
News
This Company Sets a New Milestone with World’s First Human Graphene Brain-Computer Interface
INBRAIN Neuroelectronics has announced the successful completion of the world’s first human procedure using their graphene-based brain-computer interface (BCI), a …
CluePoints Introduces Medical & Safety Review Tool to Optimize Clinical Data Management
CluePoints has launched the Medical & Safety Review (MSR) software, a new tool aimed at addressing inefficiencies in clinical data …
BioAge Labs Targets Obesity with Upsized IPO, Expected to Raise $198M to Fund Clinical Trials
BioAge Labs (Richmond, CA), a clinical-stage biopharmaceutical company developing therapies for metabolic diseases such as obesity, has announced the pricing …
Immunai and AstraZeneca Collaborate to Optimize Oncology Clinical Trials Using AI-driven Immune Mapping
Immunai, a New York-based AI biotech company, has entered a multi-year collaboration with AstraZeneca to optimize oncology clinical trials. This …
Healthcare’s Cybersecurity Crisis: A Growing Threat Amid Outdated Technology
As healthcare systems embrace digital transformation, the increased reliance on connected devices, platforms, and remote work environments has significantly expanded …
Looking Back: How Etcembly's ETCh Study is Uncovering New Cancer Targets from Survivors
Despite advances in medical science, finding a cure for cancer remains an elusive goal. Currently, only half of all people …
Generate Biomedicines Enters Up to $1 Billion Multi-Target Collaboration with Novartis to Use Generative AI for Protein Design
Generate:Biomedicines has announced a multi-target collaboration with Novartis to develop protein therapeutics using its generative AI platform. The deal, valued …
Immusoft Announces Positive Data for First Engineered B Cell Therapy in Clinical Trial
Immusoft, a biotech company focusing on cell therapy for rare diseases, has announced encouraging results from its Phase 1 clinical …
ImageBloom Launches Patient Recruitment Marketplace for Clinical Trials
ImageBloom, Inc., a provider of clinical trial support services, has launched the Patient Recruitment Marketplace, a platform designed to address …
Aston University Scientists Develop Gallium-Infused Glass Nanoparticles to Treat Osteosarcoma
Scientists from Aston University in Birmingham, led by Professor Richard Martin, have developed gallium-infused bioactive glass nanoparticles for treating osteosarcoma, …
Vortioxetine Shows Potential in Glioblastoma Treatment, Clinical Trials Planned
ETH Zurich researchers have identified vortioxetine, an FDA-approved antidepressant, as a promising candidate in the fight against glioblastoma, a highly …